4
Changes in Ownership
ENANTA PHARMACEUTICALS INC Filed Acc 0001062993-23-021384
Options or other derivatives
- Sr. VP, New Prod. Strat. & Dev acquired 83,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Kieffer Tara Lynn · Sr. VP, New Prod. Strat. & Dev
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-11-22 | Grant or award : show line 1 in the form Stock Option (right to buy) | +83,000 | 83,000 | D |
Loading xslF345X05/form4.xml…